openPR Logo
Press release

Cystic Fibrosis Pipeline Outlook Report 2024 | Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others.

03-19-2024 04:43 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Cystic Fibrosis Pipeline

Cystic Fibrosis Pipeline

DelveInsight's, "Cystic Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cystic Fibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Cystic Fibrosis Pipeline Report
• DelveInsight's Cystic Fibrosis pipeline report depicts a robust space with 75+ companies working to develop 80+ pipeline therapies for Cystic Fibrosis treatment.
• The leading companies working in the Cystic Fibrosis Market include Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, Algi Pharma, Verona Pharma, Atlantic Healthcare, Calithera Biosciences, Horizon Therapeutics, Santhera Pharmaceuticals, Reveragen Biopharma, Spli Sense, GlaxoSmithKline, EmphyCorp, Abbvie, Galapagos NV, Vertex Pharmaceuticals, PathBio Analytics, AstraZeneca, AxentisPharma AG, and others.
• Promising Cystic Fibrosis Pipeline Therapies in the various stages of development include Ciprofloxacin (Cipro Inhale, BAYQ3939), P-1037, Hypertonic Saline, VX-371 + HS, MP-376 (Levofloxacin solution for Inhalation), and others.
• October 2023: Vertex Pharmaceuticals Incorporated announced a study of phase 3 clinical trials for ELX/TEZ/IVA and IVA. This study will evaluate the pharmacokinetics (PK), safety, tolerability, pharmacodynamics (PD), and efficacy of ELX/TEZ/IVA in CF subjects 12 to less than (

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystic Fibrosis Pipeline Outlook Report 2024 | Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others. here

News-ID: 3434967 • Views:

More Releases from DelveInsight Business Research LLP

Hysteroscopy Devices Market Outlook Report 2032 by DelveInsight Exploring Market Drivers, Key Growth Challenges, Technological Advancements, and Future Market Potential
Hysteroscopy Devices Market Outlook Report 2032 by DelveInsight Exploring Market …
DelveInsight's Hysteroscopy Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Hysteroscopy Devices Companies market shares, challenges, Hysteroscopy Devices Market Drivers, barriers, trends, and key market Hysteroscopy Devices companies in the market. To read more about the latest highlights related to the Hysteroscopy Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/hysteroscopes-hysteroscopy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hysteroscopy
High Potency Active Pharmaceutical Ingredients Market Outlook Report 2032 by DelveInsight Exploring Market Drivers, Key Growth Challenges, Technological Advancements, and Future Market Potential
High Potency Active Pharmaceutical Ingredients Market Outlook Report 2032 by Del …
DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights Report 2032 provides the current and forecast market analysis, individual leading High Potency Active Pharmaceutical Ingredients Companies market shares, challenges, High Potency Active Pharmaceutical Ingredients Market Drivers, barriers, trends, and key market High Potency Active Pharmaceutical Ingredients companies in the market. To read more about the latest highlights related to the High Potency Active Pharmaceutical Ingredients Market, get a snapshot of the key
Healthcare Asset Management Market Forecast Report 2032 by DelveInsight Exploring Market Drivers, Key Growth Challenges, Technological Advancements, and Future Market Potential
Healthcare Asset Management Market Forecast Report 2032 by DelveInsight Explorin …
DelveInsight's Healthcare Asset Management Market Insights Report 2032 provides the current and forecast market analysis, individual leading Healthcare Asset Management Companies market shares, challenges, Healthcare Asset Management Market Drivers, barriers, trends, and key market Healthcare Asset Management companies in the market. To read more about the latest highlights related to the Healthcare Asset Management Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/healthcare-asset-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Anti-Retropulsion Devices Market Size Report 2032 by DelveInsight Exploring Market Drivers, Key Growth Challenges, Technological Advancements, and Future Market Potential
Anti-Retropulsion Devices Market Size Report 2032 by DelveInsight Exploring Mark …
DelveInsight's Anti-Retropulsion Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Anti-Retropulsion Devices Companies market shares, challenges, Anti-Retropulsion Devices Market Drivers, barriers, trends, and key market Anti-Retropulsion Devices companies in the market. To read more about the latest highlights related to the Anti-Retropulsion Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/anti-retropulsion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Anti-Retropulsion Devices

All 5 Releases


More Releases for Cystic

Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features. Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856 Top Company Profile Analysis in this Report- Cystic Fibrosis
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have
Cystic Fibrosis Therapeutics Market Research Reports 2017
This report studies sales (consumption) of Cystic Fibrosis Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Vertex Pharmaceuticals , F. Hoffmann-La Roche , AbbVie , Gilead Science , Novartis , AstraZeneca , Bayer , Celtaxsys , Pharmaxis , ProQR Therapeutics , PTC Therapeutics
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports. Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis". Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs